Annual Long Term Debt
$256.28 M
+$35.70 M+16.18%
31 December 2021
Summary:
Aerie Pharmaceuticals annual long term debt is currently $256.28 million, with the most recent change of +$35.70 million (+16.18%) on 31 December 2021. During the last 3 years, it has risen by +$35.70 million (+16.18%).AERI Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$332.11 M
-$437.00 K-0.13%
30 September 2022
Summary:
Aerie Pharmaceuticals quarterly long term debt is currently $332.11 million, with the most recent change of -$437.00 thousand (-0.13%) on 30 September 2022.AERI Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AERI Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +16.2% | +32.5% |
| 5 y5 years | +100.0% | +69.6% |
AERI Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | at high | -0.2% |
Aerie Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $332.11 M(-0.1%) |
| June 2022 | - | $332.55 M(-0.0%) |
| Mar 2022 | - | $332.71 M(+29.8%) |
| Dec 2021 | $256.28 M(+16.2%) | $256.28 M(+2.2%) |
| Sept 2021 | - | $250.69 M(+8.0%) |
| June 2021 | - | $232.05 M(+2.7%) |
| Mar 2021 | - | $226.00 M(+2.5%) |
| Dec 2020 | $220.58 M(+9.9%) | $220.58 M(+2.4%) |
| Sept 2020 | - | $215.45 M(+2.8%) |
| June 2020 | - | $209.66 M(+2.4%) |
| Mar 2020 | - | $204.66 M(+1.9%) |
| Dec 2019 | $200.75 M(>+9900.0%) | $200.75 M(+2.5%) |
| Sept 2019 | - | $195.79 M(+1379.0%) |
| June 2019 | - | $13.24 M(+9.9%) |
| Mar 2019 | - | $12.04 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00(-100.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2018 | - | $124.00 M(+0.1%) |
| Mar 2018 | - | $123.92 M(+0.1%) |
| Dec 2017 | $123.84 M(+0.2%) | $123.84 M(+0.1%) |
| Sept 2017 | - | $123.77 M(+0.1%) |
| June 2017 | - | $123.69 M(+0.1%) |
| Mar 2017 | - | $123.61 M(+0.1%) |
| Dec 2016 | $123.54 M(+0.2%) | $123.54 M(+0.1%) |
| Sept 2016 | - | $123.46 M(+0.1%) |
| June 2016 | - | $123.39 M(+0.1%) |
| Mar 2016 | - | $123.31 M(+0.1%) |
| Dec 2015 | $123.24 M(+0.3%) | $123.24 M(-0.8%) |
| Sept 2015 | - | $124.25 M(+0.0%) |
| June 2015 | - | $124.22 M(+0.0%) |
| Mar 2015 | - | $124.19 M(+1.0%) |
| Dec 2014 | $122.91 M | $122.91 M(-1.0%) |
| Sept 2014 | - | $124.13 M |
FAQ
- What is Aerie Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Aerie Pharmaceuticals?
- What is Aerie Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Aerie Pharmaceuticals?
What is Aerie Pharmaceuticals annual long term debt?
The current annual long term debt of AERI is $256.28 M
What is the all time high annual long term debt for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high annual long term debt is $256.28 M
What is Aerie Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of AERI is $332.11 M
What is the all time high quarterly long term debt for Aerie Pharmaceuticals?
Aerie Pharmaceuticals all-time high quarterly long term debt is $332.71 M